A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular

April 12, 2018 updated by: Xiaoping Chen, Huazhong University of Science and Technology

A New Prognostic Scoring System for Spontaneous Ruptured Hepatocellular Carcinoma: A Retrospective Study

Develop a new scoring system for HCC patients with tumor rupture.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

There has been no special prognostic scoring system for HCC patients with tumor rupture in the literature. In this work, we obtained all survival risk factors of ruptured HCC patients who underwent partial hepatectomy using multivariable Cox regression analysis. Furthermore, we develop and validate a new postoperative scoring system for patients with spontaneous HCC rupture based on the these results.

Study Type

Observational

Enrollment (Actual)

129

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

15 years to 75 years (Child, Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

Ten year HCC rupture patients who received partial hepatectomy at Tongji Hospital of the Huazhong University of Science and Technology

Description

Inclusion Criteria:

  • Received partial hepatectomy; with Child A or B liver function.

Exclusion Criteria:

  • Without complete data;loss of follow-up; had reveived repeated transcatheter arterial chemoembolization before rupture; received non-radical resection.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Retrospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
Analysis before liver resection
Multivariate analysis of predictive factors associated with survival
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.
Different risk group
Low-risk group, moderate-risk group, high-risk group
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.
Model comparison
Comparison of models in predicting survival
Partial hepatectomy comprised single or multiple hepatic resections aiming at excising all visible malignant tissue.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Overall survival
Time Frame: 3 years
Overall survival after partial hepatectomy
3 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Disease-free survival
Time Frame: 3 years
Recurrence-free survival after partial hepatectomy
3 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Bi-xiang Zhang, Prof, PHD, Huazhong University of Science and Technology

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2005

Primary Completion (Actual)

May 1, 2015

Study Completion (Actual)

December 31, 2017

Study Registration Dates

First Submitted

April 4, 2018

First Submitted That Met QC Criteria

April 12, 2018

First Posted (Actual)

April 20, 2018

Study Record Updates

Last Update Posted (Actual)

April 20, 2018

Last Update Submitted That Met QC Criteria

April 12, 2018

Last Verified

April 1, 2018

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Rupture, Spontaneous

Clinical Trials on Liver resection

Subscribe